Group One Trading’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,200
| Closed | -$14.5K | – | 5798 |
|
|
2019
Q2 | $15K | Buy |
1,200
+900
| +300% | +$11.9K | ﹤0.01% | 4295 |
|
|
2019
Q1 | $4K | Buy |
+300
| New | +$3.83K | ﹤0.01% | 4504 |
|
|
2018
Q1 | – | Sell |
-3,588
| Closed | -$59.8K | – | 5545 |
|
|
2017
Q4 | $50K | Buy |
+3,588
| New | +$48.5K | ﹤0.01% | 3736 |
|
|
2016
Q4 | – | Sell |
-3,384
| Closed | -$40K | – | 5032 |
|
|
2016
Q3 | $40K | Buy |
+3,384
| New | +$39.8K | ﹤0.01% | 3473 |
|
|
2016
Q2 | – | Sell |
-78
| Closed | -$805 | – | 5097 |
|
|
2016
Q1 | $1K | Hold |
78
| – | – | ﹤0.01% | 4470 |
|
|
2015
Q4 | $1K | Sell |
78
-1,853
| -96% | -$31K | ﹤0.01% | 4639 |
|
|
2015
Q3 | $32K | Sell |
1,931
-5,818
| -75% | -$119K | ﹤0.01% | 3807 |
|
|
2015
Q2 | $177K | Buy |
7,749
+2,712
| +54% | +$54K | ﹤0.01% | 2621 |
|
|
2015
Q1 | $77K | Buy |
+5,037
| New | +$65.4K | ﹤0.01% | 3077 |
|
|
2014
Q4 | – | Sell |
-3,191
| Closed | -$36.5K | – | 5449 |
|
|
2014
Q3 | $36K | Sell |
3,191
-27,342
| -90% | -$312K | ﹤0.01% | 3767 |
|
|
2014
Q2 | $369K | Buy |
30,533
+10,482
| +52% | +$124K | 0.01% | 1895 |
|
|
2014
Q1 | $234K | Buy |
20,051
+4,721
| +31% | +$79.9K | ﹤0.01% | 2317 |
|
|
2013
Q4 | $271K | Buy |
+15,330
| New | +$258K | ﹤0.01% | 2170 |
|
Group One Trading's MNTA Position: Q3 2019 in Review
Group One Trading sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2019, closing a stake of 1,200 shares — an estimated $14.5K sold.
Group One Trading first reported a position in MNTA in Q4 2013 and held it in 13 quarters. The position peaked at $369K in Q2 2014. 154 funds tracked by Wall St. Rank hold MNTA as of Q3 2019.
- Group One Trading reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
- Group One Trading sold 1,200 Momenta Pharmaceuticals, Inc. shares in Q3 2019, an estimated $14.5K.
- Group One Trading first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 13 quarters.
- Group One Trading's Momenta Pharmaceuticals, Inc. position peaked at $369K in Q2 2014.
- 154 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2019.
Based on Group One Trading's 13F filing for Q3 2019, filed 12 Nov 2019.